Cresco Financial Statements From 2010 to 2024
| CRLBF Stock | USD 1.09 0.06 5.22% |
Check Cresco Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cresco Labs' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cresco financial statements analysis is a perfect complement when working with Cresco Labs Valuation or Volatility modules.
Cresco |
Cresco Labs OTC Stock Operating Margin Analysis
Cresco Labs' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cresco Labs Operating Margin | 0.13 % |
Most of Cresco Labs' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cresco Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Cresco Labs has an Operating Margin of 0.126%. This is 100.36% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 102.29% lower than that of the firm.
Cresco Labs Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cresco Labs's current stock value. Our valuation model uses many indicators to compare Cresco Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cresco Labs competition to find correlations between indicators driving Cresco Labs's intrinsic value. More Info.Cresco Labs is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cresco Labs' earnings, one of the primary drivers of an investment's value.About Cresco Labs Financial Statements
Cresco Labs stakeholders use historical fundamental indicators, such as Cresco Labs' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cresco Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cresco Labs' assets and liabilities are reflected in the revenues and expenses on Cresco Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cresco Labs. Please read more on our technical analysis and fundamental analysis pages.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company was founded in 2013 and is headquartered in Chicago, Illinois. Cresco Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3300 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Cresco OTC Stock
Cresco Labs financial ratios help investors to determine whether Cresco OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cresco with respect to the benefits of owning Cresco Labs security.